Daniela Abt

TL;DR: To evaluate the experiences of families with very young children aged 1 to 7 years (inclusive) with type 1 diabetes using day‐and‐night hybrid closed‐loop insulin delivery, a large number of families opted for the day-and-night approach.

TL;DR: Unrestricted home use of day-and-night closed-loop in very young children with type 1 diabetes is feasible and safe and the use of diluted insulin during closed- loop does not provide additional benefits compared with standard strength insulin.

TL;DR: Skin-related complications during CSII are frequent and regular examination of the insertion sites is crucial, and larger studies would be needed to verify the occurrence of lipoatrophy associated with insulin pump therapy - an otherwise rare complication.

TL;DR: Careful monitoring provides an alternative to surgery and lowers the risk of muscular necrosis in a physically very active and slim 10‐year‐old boy with reduced subcutaneous fatty tissue.

TL;DR: In this paper, the authors conducted a baseline assessment in parents to study the association between hypoglycemia fear, parental well-being and child behavior, and found a higher score for the hypoglycemic fear behavior 33.9 ± 5.6 compared to hypoglyncemia worry 34.6 ± 12.2.